October 2022 Federal Circuit Newsletter (Japanese) October 2022 Federal Circuit Newsletter (Chinese) Avoiding § 101 Eligibility Issues in Internet-Centric Method Claims In Weisner v. Google LLC, Appeal No. 21-2228,…
September 2022 Federal Circuit Newsletter (Japanese) September 2022 Federal Circuit Newsletter (Chinese) Duplicative-Litigation Doctrine: Proper Motion Practice is Essential to Avoid Dismissal of Duplicative Complaints In Arendi S.A.R.L. v. LG…
August 2022 Federal Circuit Newsletter (Japanese) August 2022 Federal Circuit Newsletter (Chinese) Inventors, Not Ai-Ventors: An “Inventor” Must Be a Natural Person In Thaler v. Vidal, Appeal No. 21-2347,…
July 2022 Federal Circuit Newsletter (Japanese) July 2022 Federal Circuit Newsletter (Chinese) Unforced Error: An IPR Challenger Cannot Rely on an Error That a POSITA Would Have Corrected In…
June 2022 Federal Circuit Newsletter (Japanese) June 2022 Federal Circuit Newsletter (Chinese) Claims With Clerical Errors Can Be Judicially Corrected and Willfully Infringed In Pavo Solutions LLC v. Kingston…
May 2022 Federal Circuit Newsletter (Japanese) May 2022 Federal Circuit Newsletter (Chinese) Somebody’s Wrong: PTAB Must Resolve Conflicting Factual Testimony During IPR In Google LLC v. IPA Technologies Inc., Appeal…
April 2022 Federal Circuit Newsletter (Japanese) April 2022 Federal Circuit Newsletter (Chinese) A Construction That Eliminates the Entire Scope of Dependent Claims Should Be Avoided Littelfuse, Inc. v. Mersen USA…
March 2022 Federal Circuit Newsletter (Japanese) March 2022 Federal Circuit Newsletter (Chinese) Claim Limitation Not Disclosed by Any Reference but Disclosed by “Proposed Combination” of References Is Obvious In…
February 2022 Federal Circuit Newsletter (Japanese) February 2022 Federal Circuit Newsletter (Chinese) Ordered To Agree: Binding Settlement Agreement Provision Found Despite Absence of Singular, Executed Agreement In Plasmacam, Inc….
January 2022 Federal Circuit Newsletter (Japanese) January 2022 Federal Circuit Newsletter (Chinese) Silence May Support Negative Claim Limitation In Novartis Pharmaceuticals v. Accord Healthcare Inc. Appeal No. 21-1070, the…
